Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 Trial

Chronic hepatitis B (CHB) remains a major worldwide public health concern. Besifovir dipivoxil maleate (BSV) is a new promising treatment for CHB. However, long-term efficacy and safety have not yet been evaluated. Therefore, the goal of the study is to determine the antiviral efficacy and safety of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Am J Gastroenterol
Autori principali: Yim, Hyung Joon, Kim, Won, Ahn, Sang Hoon, Yang, Jin Mo, Jang, Jae Young, Kweon, Yong Oh, Cho, Yong Kyun, Kim, Yoon Jun, Hong, Gun Young, Kim, Dong Joon, Jung, Young Kul, Um, Soon Ho, Sohn, Joo Hyun, Lee, Jin Woo, Park, Sung Jae, Lee, Byung Seok, Kim, Ju Hyun, Kim, Hong Soo, Yoon, Seung Kew, Kim, Moon Young, Lee, Kwan Sik, Lim, Young Suk, Lee, Wan Sik, Han, Kwang-Hyub
Natura: Artigo
Lingua:Inglês
Pubblicazione: Wolters Kluwer 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7402376/
https://ncbi.nlm.nih.gov/pubmed/32355123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14309/ajg.0000000000000605
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi